OFFICIALS LEGISLATION INTEREST GROUPS PUBLIC STATEMENTS COMMITTEES VETOES

Letter to the Hon. Norman Sharpless, Acting Commissioner of the U.S. Food and Drug Administration - Lack of Generic Insulin Causes Hardship for Millions of American Diabetics

Letter

Date: July 16, 2019
Location: Washington D.C.
Issues: Health Insurance

Only available in PDF format; please see source to view document


Source
arrow_upward